Paper

4'-methoxy-2-styrylchromone a novel microtubule-stabilizing antimitotic agent.

Published Feb 15, 2008 · DOI · J. Marinho, M. Pedro, D. Pinto

Biochemical pharmacology

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

4'-methoxy-2-styrylchromone selectively inhibits human tumor cell growth by blocking the G2/M phase of the cell cycle and disrupting microtubules, suggesting potential as a new anti-tumor agent.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

4'-methoxy-2-styrylchromone a novel microtubule-stabilizing antimitotic agent.

References

Citations